Serum Biomarker Levels Compared to Breast Cancer Stage

A clinical dataset compares serum levels of IGF-1, IGFBP-3, and HER-2 with the stage of breast cancer among patients. The dataset is 5.5 KB in size and was authored by Heba Mohammed Arafat. It was last updated on June 1, 2026.

Use Cases

• Correlate biomarker levels with cancer progression based on IGF-1, IGFBP-3, and HER-2 measurements.
• Train predictive models for cancer stage classification based on serum biomarker profiles.
• Analyze the relationship between specific protein levels and disease severity in breast cancer patients.

Strengths

• Dataset is openly licensed under CC-BY-4.0.
• File size is 5.5 KB, indicating a focused and manageable dataset.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

figshare

Freshness

Last updated 2026-06-01 17:31:37; freshness should be verified.